New Covid Seroconversion Panels for Medical Research and Assay Development

MRN Diagnostics
MRN Diagnostics
  • Home
  • About Us
  • Online Store
  • Products
    • Biorepository Products
    • Blood Typing Cards
    • COV Seroconversion Panels
    • COVID-19
    • Commercial Launch
    • Diag. Development Panels
    • Diagnostic Manufacturing
    • Proficiency Panels
    • Specimen Collections
  • Services
  • Facilties
  • Contact Us
  • MRN Certifications
  • Legal Documents
  • Resource Library
  • More
    • Home
    • About Us
    • Online Store
    • Products
      • Biorepository Products
      • Blood Typing Cards
      • COV Seroconversion Panels
      • COVID-19
      • Commercial Launch
      • Diag. Development Panels
      • Diagnostic Manufacturing
      • Proficiency Panels
      • Specimen Collections
    • Services
    • Facilties
    • Contact Us
    • MRN Certifications
    • Legal Documents
    • Resource Library
  • Sign In
  • Create Account

  • Orders
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Orders
  • My Account
  • Sign out


Signed in as:

filler@godaddy.com

  • Home
  • About Us
  • Online Store
  • Products
    • Biorepository Products
    • Blood Typing Cards
    • COV Seroconversion Panels
    • COVID-19
    • Commercial Launch
    • Diag. Development Panels
    • Diagnostic Manufacturing
    • Proficiency Panels
    • Specimen Collections
  • Services
  • Facilties
  • Contact Us
  • MRN Certifications
  • Legal Documents
  • Resource Library

Account


  • Orders
  • My Account
  • Sign out


  • Sign In
  • Orders
  • My Account

Resource Library

Clinical Trial Guidance

FDA guidance on the design of Pivotal IVD Clinical Studies

FDA guidance on significant or non-significant risk studies (2006) 

FDA guidance on Clinical Investigator Financial Disclosure 

Informed Consent FDA Guidance (2012) 

IVD Regulatory Guidance

Overview of FDA regulations for IVDs 

FDA Frequently Asked Questions on IVDs and IVD regulations

Assistance from FDA (Device Advice) 

IVD Labeling guidelines

Pre-submission meetings, FDA Guidance (2012)  

Listing of FDA approved Nucleic Acid Based test

Companion Diagnostics

Draft FDA guidance on Companion Diagnostics

RAPS Commentary on Companion Diagnostics (2013)

Commentary on FDA Companion 

CLIA Certification Guidance

General CLIA Guidance from CDC

CLIA Guidance from CDRH

CDC CLIA Guidelines

Laboratory Developed Tests White Paper

IDE Guidance

FDA Guidance on IDE Policy and Procedure

FDA IDE Approval Process Guidance

Holbein ME, BerglundJP.  Understanding Food and Drug Administration regulatory requirements for an investigational device exemption for sponsor-investigators.  J Investig Med. 2012;60:987-94.

FDA Guidance on Investigator Responsibilities for Significant Risk studies

FDA Guidance on Sponsor’s responsibilities for Significant Risk studies

Product Development

Design Control Guidance (1997)  

Resource Library

  • Home
  • About Us
  • Services
  • Contact Us
  • Resource Library

MRN Diagnostics

101 Constitution Boulevard, Franklin, Massachusetts 02038, United States

508-384-0033

Copyright © 2020 Medical Research Networx, LLC. - All Rights Reserved.

ph: (508) 384-0033 fax (508) 384-0044

info@mrndx.com

Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies.

Accept & Close